17-6695759-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_177550.5(SLC13A5):c.1022G>A(p.Trp341Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,614,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_177550.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC13A5 | NM_177550.5 | c.1022G>A | p.Trp341Ter | stop_gained | 7/12 | ENST00000433363.7 | NP_808218.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC13A5 | ENST00000433363.7 | c.1022G>A | p.Trp341Ter | stop_gained | 7/12 | 1 | NM_177550.5 | ENSP00000406220 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251188Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135776
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461878Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 727238
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74338
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 25 Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2022 | This sequence change creates a premature translational stop signal (p.Trp341*) in the SLC13A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC13A5 are known to be pathogenic (PMID: 24995870, 26384929). This variant is present in population databases (rs150203483, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with early infantile epileptic encephalopathy (PMID: 26384929). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 218171). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2015 | - - |
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Nov 02, 2021 | The p.Trp341Ter variant in SLC13A5 has been reported in 3 individuals with developmental and epileptic encephalopathy (PMID: 26384929, 32551328), segregated with disease in 1 affected relative from 1 family (PMID: 26384929), and has been identified in 0.004% (5/1134840) of European (Non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs150203483). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of the 2 affected probands, 1 was a compound heterozygote that carried a variant of uncertain significance in trans which increases the likelihood that the p.Trp341Ter variant is pathogenic (Variation ID: 140752; PMID: 32551328, 26384929) This variant has also been reported in ClinVar (Variation ID#: 218171) and has been interpreted as pathogenic by Invitae and OMIM. In vitro functional studies provide some evidence that the p.Trp341Ter variant may slightly impact protein function (PMID: 26384929). However, these types of assays may not accurately represent biological function. This nonsense variant leads to a premature termination codon at position 341, which is predicted to lead to a truncated or absent protein. Loss of function of the SLC13A5 gene is strongly associated to autosomal recessive developmental and epileptic encephalopathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive developmental and epileptic encephalopathy. ACMG/AMP Criteria applied: PVS1_strong, PM2_supporting, PM3_supporting, PS3_supporting (Richards 2015). - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 01, 2022 | Published functional studies demonstrate a damaging effect (Hardies et al., 2015); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27261973, 26384929, 32551328, 24995870, 33063863) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at